Nordicus Partners (NORD) Common Equity (2009 - 2026)
Nordicus Partners (NORD) reported Common Equity of $61.59 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 4.2% from $64.26 million a year earlier and down 4.2% from the prior quarter.
Powered by 
Analysis
Nordicus Partners (NORD) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Nordicus Partners posted Common Equity of $64.28 million, up 7.4% from FY2025.
- Common Equity has a five-year compound annual growth rate of 279.2% (FY2021 to FY2026).
- By fiscal year, Common Equity came in at $59.87 million in FY2025, $1.78 million in FY2024, $27,658 in FY2023 (-85.8%) and $194,511 in FY2022 (+137.2%).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Common Equity since fiscal Q4 2025.
- Year over year, Common Equity gained in four of the last five quarters, with growth averaging 84.5%.
- The high point for year-over-year Common Equity in five years was fiscal Q1 2024 (growth of 941.9%); the low point was fiscal Q4 2023 (a decline of 85.8%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $64.28 million (Q4 2026), $64.77 million (Q3 2026) and $64.67 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Nordicus Partners | 55.60 Mn | 55.07 Mn | - | 61.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.59 Mn |
| Mar 31, 2026 | 64.28 Mn |
| Dec 31, 2025 | 64.77 Mn |
| Sep 30, 2025 | 64.67 Mn |
| Jun 30, 2025 | 64.26 Mn |
| Mar 31, 2025 | 59.87 Mn |
| Dec 31, 2024 | 59.28 Mn |
| Sep 30, 2024 | 21.08 Mn |
| Jun 30, 2024 | 21.19 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 1.76 Mn |
| Mar 31, 2023 | 27,658.00 |
| Dec 31, 2022 | 96,397.00 |
| Sep 30, 2022 | 122,476.00 |
| Jun 30, 2022 | 169,148.00 |
| Mar 31, 2022 | 194,511.00 |
| Dec 31, 2021 | 48,000.00 |
| Sep 30, 2021 | -112,000.00 |
API Access
Nordicus Partners Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NORD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NORD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NORD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();